Radio and PodcastLive Radio & Podcasts
Science & Medicine
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression
BUFFALO, NY – April 15, 2026 – A new paper was in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregulation and biological function of PDX1 in prostate cancer.” The study was led by first author Tayo A....
About This Episode
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression is an episode from Oncotarget by Oncotarget Podcast. BUFFALO, NY – April 15, 2026 – A new paper was in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregu...
Podcast
This episode belongs to Oncotarget.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 15, 2026, 00:02:40 long, audio available.
Related Episodes
Continue listening to more episodes from Oncotarget.
Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US
Jun 29, 2026 - 00:06:17
TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
Jun 24, 2026 - 00:04:28
Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response
Jun 17, 2026 - 00:04:33
PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression
Jun 16, 2026 - 00:08:07
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
Jun 15, 2026 - 00:04:36
Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer
Jun 8, 2026 - 00:05:14